Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Viseon
AddedFeb 15, 2024
UpdatedJun 18, 2026
Viseon

Viseon

Series B

Viseon pioneers in single-use imaging technology for minimally invasive spine surgery.

HQ
Irvine, CA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Viseon, a medical device company, was founded to revolutionize minimally invasive spine surgery (MISS) by introducing the first and only state-of-the-art single-use disposable imaging technology. The company's core mission is to enhance surgical precision, efficiency, and safety through advanced visualization tools. Viseon's flagship product, MaxView®, offers brilliant 4K video imaging and integrated video recording, significantly improving the visualization experience in and out of the operating room. Their market focus is on healthcare providers specializing in MISS.

Notable affiliated individuals and investors include experts in medical technology and venture capitalists committed to advancing surgical innovations. Viseon has achieved significant milestones, including the successful launch and adoption of MaxView® in various medical institutions. The company's impact is evident in its contribution to improving surgical outcomes and patient care in spine surgery through cutting-edge imaging solutions.

Viseon - Similar Companies

IntraVu logo

IntraVu

intravu.com

VisionScope Technologies logo

VisionScope Technologies

Minimus Spine logo

Minimus Spine

Vertebral Technologies logo

Vertebral Technologies

Nanovis logo

Nanovis

Visie logo

Visie

visievision.com

New View Surgical logo

New View Surgical

newviewsurg.com

SpineOvations logo

SpineOvations

Spinal Simplicity logo

Spinal Simplicity

Spine Wave logo

Spine Wave

spinewave.com

Spineology logo

Spineology

spineology.com

Visunex Medical Systems logo

Visunex Medical Systems

Verdure Imaging logo

Verdure Imaging

verdureimaging.com

Visura Technologies logo

Visura Technologies

Vertos Medical logo

Vertos Medical

vertosmed.com

Viseon - Quick Facts

Who are Viseon's competitors?

Companies similar to Viseon include IntraVu, VisionScope Technologies, Minimus Spine and Vertebral Technologies.

When was Viseon founded?

Viseon was founded in 2017.

Where is Viseon's headquarters located?

Viseon's headquarters is located in Irvine, CA, US.

When was Viseon's last funding round?

Viseon's most recent funding round was for $18M (USD) in February 2020.

How much has Viseon raised to-date?

As of Feb 25, 2020, Viseon has raised a total of $23M (USD).

How many employees does Viseon have?

Viseon has 40 employees as of Feb 5, 2024.

Viseon - Classification

Industry
  • Hardware
Ownership
  • Private Equity
  • Venture Capital
Technology
  • Medical Devices
Geographic Exposure
  • Americas
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified